Business Wire

RECELL® Pivotal Trial in Third-Degree Burns Meets Co-Primary Endpoints and Shows Statistically Significant Reduction in Donor Skin Requirements

One burn site was treated with the standard treatment, meshed autograft, while the other was treated with the combination of the RECELL Device and more widely meshed autografted (for example, if a 2:1 ...
Business Wire

AVITA Medical Announces RECELL® Data Demonstrating Statistically Significant Reduction in Donor Skin Requirements and Pain, Increased Patient Satisfaction and Improved Donor ...

VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Medical (ASX: AVH) (OTCQX: AVMXY) announced today that results from a pivotal clinical trial demonstrating the effectiveness and ...
BioWorld

Avita’s Recell pivotal trial sees mixed results for soft tissue reconstruction

Regenerative medicine company Avita Medical Ltd. reported that topline results were mixed for its pivotal trial evaluating the safety and effectiveness of its Recell system combined with meshed ...
Nasdaq

AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELL

VALENCIA, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today highlighted ...
Nasdaq

Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment

Global evidence and real-world data demonstrate the clinical, operational, and economic impact of AVITA Medical’s RECELL System across wound types and patient populations VALENCIA, Calif., Nov. 03, ...
Benzinga.com

AVITA Medical Shares Climb On Topline Results From Soft Tissue Reconstruction Study, Sees PMA Submission By Year-end

AVITA Medical RCEL announced topline results from its pivotal trial evaluating the safety and effectiveness of the RECELL System combined with meshed autograft for reduction of donor skin harvesting ...
News Medical

AVITA Medical announces results revealing safety, effectiveness of RECELL System for burn care

AVITA Medical , a global regenerative medicine company, today announced that the results from two U.S. pivotal clinical trials demonstrating the effectiveness and clinical benefits of the RECELL ® ...
Yahoo Finance

FDA Approves Continued Access to ReCell(R) in US Burns Trial

NORTHRIDGE, CA and PERTH, AUSTRALIA and LONDON, UNITED KINGDOM--(Marketwired - Oct 4, 2016) - The US Food and Drug Administration has approved Continued Access to ReCell, allowing US burns surgeons ...
Seeking Alpha

CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds

VALENCIA, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- AVITA Medical (RCEL) ®, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company, today ...
Seeking Alpha

Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment

VALENCIA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (RCEL) (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or the “Company”), a leading therapeutic acute wound care company, today ...